This mix may benefit athletes and people with long-term injuries
The drugs would still not be FDA-approved, and the FDA would still not vouch for their safety or effectiveness. Koehl Robinson, founder and CEO of CeliaRX, a telehealth company that sells injectable and topical peptides compounded by a 503A pharmacy partner (not the ones on the FDAs potential unbanned list), says that if the peptides are reclassified, it would likely open up new possibilities for her customers, as well as lead to more clarity and less confusion
doi.org/10.3389/fphys.2018.00044 Bentov Y, Hannam T, Jurisicova A, Esfandiari N, Casper RF
It works by stimulating angiogenesis (the formation of new blood vessels), reducing inflammation, and increasing fibroblast activity all critical for tissue regeneration and wound healing